Lead Product(s) : RCS-01
Therapeutic Area : Dermatology
Study Phase : Phase I
Sponsor : JensonR+ | PHARMALOG Institute | Syreon Corporation | Innovacell Biotechnologie | Datinf GmbH
Deal Size : Inapplicable
Deal Type : Inapplicable
Study of Intradermal Injections of RCS-01 in Male and Female Subjects
Details : Undisclosed
Product Name : Undisclosed
Product Type : Cell and Gene therapy
Upfront Cash : Inapplicable
March 18, 2015
Lead Product(s) : RCS-01
Therapeutic Area : Dermatology
Highest Development Status : Phase I
Sponsor : JensonR+ | PHARMALOG Institute | Syreon Corporation | Innovacell Biotechnologie | Datinf GmbH
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
